Jim Cramer talks his takeaways from the JPMorgan healthcare conference

Investing is rarely about what's important, it's about making money, says Jim CramerПодробнее

Jim Cramer takes the pulse of the healthcare industry at JPMorgan's healthcare conferenceПодробнее

The JPMorgan healthcare conference will be market-moving, says Jim CramerПодробнее

I am liking what i'm seeing at the JPMorgan Healthcare Conference, says Jim CramerПодробнее

Jim Cramer talks how CEOs are viewing the business environmentПодробнее

J.P. Morgan’s Lisa Gill: Healthcare Conference Preview | Mad Money | CNBCПодробнее

J.P. Morgan's Dimon takes risk criticizing Trump, says Jim CramerПодробнее

Jim Cramer: Celgene buyers going to do greatПодробнее

Cramer's First Take: JPMorgan Chase got a great dealПодробнее

JP Morgan's app is targeting millennials, but this isn't what they want, says Jim CramerПодробнее

JP Morgan's Dimon: Haven't seen actual regulatory change for large banksПодробнее

Jim Cramer on upcoming bank earnings from JP Morgan and Goldman SachsПодробнее

Healthcare sector poised for rebound in 2025Подробнее

Boston Scientific (BSX) on CNBC Mad Money with Jim CramerПодробнее

Cramer's Stop Trading: CelaneseПодробнее

Jim Cramer: Everyone knew that December would be weak for JP Morgan:Подробнее

JPMorgan's Lisa Gill previews health-care conference and explains why she sees more upside for CVSПодробнее

Jim Cramer: 'We're in trouble' if JP Morgan's stock doesn't rally when it reports earningsПодробнее

What Investors Need to Know About Bank Earnings, JPMorgan's Healthcare Conference and LululemonПодробнее